SOPHARMA: strona spółki
22.12.2025, 14:04
SPH Sales revenues for November
Sofia, Bulgaria, December 22, 2025 – According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that for November 2025 the Company recorded increase in sales of 46% compared to the same month of the previous year, incl. 22% increase in domestic sales and 66% increase in export sales.
For the period since the beginning of 2025, the Company has achieved sales increase of 12%, including 2% increase in domestic sales and 19% increase in export sales.
For the period since the beginning of 2025, the Company has achieved sales increase of 12%, including 2% increase in domestic sales and 19% increase in export sales.